ISV-Girona

Girona Vascular Health Research Group

The ISV group is fully integrated in the cardiovascular area of the IDIAP since the main researcher of the group is, in turn, the area coordinator. He has participated with great involvement in the cardiovascular group of the AIAPP network through the leadership of the CARDIOCAT group (the seven members of the ISV group belong to CARDIOCAT and its IP also belongs to the CARDIOCAT). On the other hand, it is also present through its PI (which performs the tasks of coordinator) in the vascular prevention group of the Vascular Diseases Plan of the Department of Health of the Generalitat de Catalunya. The members of the ISV belong to different areas of the Primary Health care system, including management, teaching, patient care and research. The central research objective of the group is to improve the detection and management of patients with intermediate cardiovascular risk, the detection of CV disease in the asymptomatic phase and to analyze the cost effectiveness of interventions for the prevention of cardiovascular disease.

The group participates in the following projects

PI: Ramos Blanes, Rafel. Drug Utilisation Study extension (DUS ext.) of valproate and related substances, in Europe, using databases. Funding: IQVIA LTD. Duration: 2020 - 2023

PI: Ramos Blanes, Rafel. Stratification of Obese Phenotypes to Optimize Future Obesity Therapy. Funding: Institut d'Investigació Biomèdica de Girona (IDIBGI). Duration: 2020 - 2022

PI: Ramos Blanes, Rafel. Girona, regió saludable - Imagenoma de la salut. Funding: ICS - Institut Català de la Salut. Duration: 2020 - 2021

PI: Ramos Blanes, Rafel. Drug utilization of Intrarosa (6.5 mg prasterone pessary) in European Countries. Funding: IQVIA AG. Duration: 2020

PI: Ramos Blanes, Rafel. Estils de vida, característiques sociodemogràfiques i econòmiques, discapacitat, dolor, qualitat de vida, impulsivitat, suport social, i prevalença de factors de risc i de malalties cròniques de la població adulta de la província de Girona. (Girona, regió saludable). Funding: ICS - Institut Català de la Salut. Duration: 2019 - 2020

Group publications

Dégano IR, Ramos R, García-Gil M, Zamora A, Comas-Cufí M, Francés A, Garcia-Elias A, Marrugat J. Three-year events and mortality in cardiovascular disease patients without lipid-lowering treatment. Eur J Prev Cardiol. 2020 Dec; 27(19):2102-2104. doi:10.1177/2047487319862103. Epub 2019 Jul 09. PMID:31288537. IF: 5,864.

The group participates in the following publications

Alves L, Comas M, Ponjoan A, Garcia M, Martí R, Blanch J, Elosua M, Parramon D, Camós L, Guzmán L, Ramos R. Levels of ankle-brachial index and the risk of diabetes mellitus complications. BMJ Open Diabetes Res Care. 2020;8(1):e000977. PMID:32144131. IF: 3,183.

Barroso M, Zomeño MD, Díaz JL, Pérez-Fernández S, Martí-Lluch R, Cordón F, Ramos R, Cabezas C, Salvador G, Castell C, Schröder H, Grau M. Control of cardiovascular risk factors with tailored recommendations: A randomized controlled trial. Prev Med. 2020 12; 141:106302. doi:10.1016/j.ypmed.2020.106302. Epub 2020 Nov 02. PMID:33144141. IF: 3,788.

Casellas-Robert M, Lim C, Lopez-Ben S, Lladó L, Salloum C, Codina-Font J, Comas-Cufí M, Ramos E, Figueras J, Azoulay D. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study. World J Surg. 2020 Nov; 44(11):3915-3922. doi:10.1007/s00268-020-05687-9. Epub 2020 Jul 13. PMID:32661688. IF: 2,234.

de Bont J, Díaz Y, Casas M, García-Gil M, Vrijheid M, Duarte-Salles T. Time Trends and Sociodemographic Factors Associated With Overweight and Obesity in Children and Adolescents in Spain. JAMA Netw Open. 2020 Mar 2;3(3):e201171. doi: 10.1001/jamanetworkopen.2020.1171. PubMed PMID: 32186743.

Félix-Redondo FJ, Subirana I, Baena-Diez JM, Ramos R, Cancho B, Fernández-Bergés D, Robles NR. [Prognostic importance of diagnosticated peripheral arterial disease through the ankle brachial index in spanish general population]. Aten Primaria. 2020 11; 52(9):627-636. doi:10.1016/j.aprim.2020.03.005. Epub 2020 Jun 03. Spanish. pmc:PMC7713094. PMID:32505482. IF: 1,087.

Forné C, Subirana I, Blanch J, Ferrieres J, Azevedo A, Meisinger C, Farmakis D, Tavazzi L, Davoli M, Ramos R, Brosa M, Marrugat J, Dégano IR; EUROTRACS Investigators. A cost-utility analysis of increasing percutaneous coronary intervention use in elderly patients with acute coronary syndromes in six European countries. Eur J Prev Cardiol. 2020 Jul; doi:10.1177/2047487320942644. Epub 2020 Jul 20. PMID:32689836. IF: 5,864.

Garre-Olmo J, Turró-Garriga O, Martí-Lluch R, Zacarías-Pons L, Alves-Cabratosa L, Serrano-Sarbosa D, Vilalta-Franch J, Ramos R; Girona Healthy Region Study Group. Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study. Compr Psychiatry. 2021 01; 104:152214. doi:10.1016/j.comppsych.2020.152214. Epub 2020 Oct 20. pmc:PMC7574785. PMID:33186837. IF: 2,567.

Gil-Terrón N, Cerain-Herrero MJ, Subirana I, Rodríguez-Latre LM, Cunillera-Puértolas O, Mestre-Ferrer J, Grau M, Dégano IR, Elosua R, Marrugat J, Ramos R, Baena-Díez JM, Salvador-González B. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region. Rev Esp Cardiol (Engl Ed). 2020 Mar; 73(3):212-218. doi:10.1016/j.rec.2018.12.006. Epub 2019 Jan 30. PMID:30709697. IF: 4,642.

Janssen O, Vos SJB, García-Negredo G, Tochel C, Gustavsson A, Smith M, Ly A, Nelson M, Baldwin H, Sudlow C, Bexelius C, Jindra C, Vaci N, Bauermeister S, Gallacher J, Ponjoan A, Dufouil C, Garre Olmo J, Pedersen L, Skoog I, Hottgenroth A, Visser PJ, van der Lei J, Diaz C. Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube. Alzheimers Dement. 2020 Mar; 16(3):461-471. doi:10.1016/j.jalz.2019.09.087. Epub 2020 Jan 06. PMID:32157788. IF: 17,127.

NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. Epub 2020 Jun 3. PMID: 32494083; PMCID: PMC7332422. IF: 42,779.

Ponjoan A, Garre J, Blanch J, Fages E, Alves L, Martí R, Comas M, Parramon D, Garcia M, Ramos R. Is it time to use real-world data from primary care in Alzheimer's disease?. Alzheimers Res Ther. 2020;12(1):60-60. PMID:32423489. IF: 6,116.

Puig J, Biarnes C, Pedraza S, Vilanova JC, Pamplona R, Fernández-Real JM, Ramos R, Coll G,Calvo-Perxas L, Serena J, Ramió-Torrentà L, Gich J, Gallart L, Portero-Otin M, Alberich-Bayarri A, Jimenez-Pastor A, Camacho-Ramos E, Mayneris-Perxachs J, Pineda V, Font R, Prats-Puig A, Gacto ML, Deco G, Escrichs A, Clotet B, Paredes R, Negredo E, Triaire B, Rodríguez M, Heredia-Escámez A, Coronado R, de Graaf W, Prevost V, Mitulescu A, Daunis-I-Estadella P, Thió-Henestrosa S, Miralles F, Ribas-Ripoll V, Puig-Domingo M, Essig M, Figley CR, Figley TD, Albensi B, Ashraf A, Reiber JHC, Schifitto G, Md Nasir U, Leiva-Salinas C, Wintermark M, Nael K, Vilalta-Franch J, Barretina J, Garre J. The Aging Imageomics Study: rationale, design and baseline characteristics of the study population. Mech Ageing Dev. 2020; 189:111257. PMID:32437737. IF: 4,304.

Indicators

Indicator

2020

Researchers with PhD

9

Total number of projects in which group members have participated

11

Total number of projects in which the PI of the project has belonged to the group

9

Total Funding

249.550,8 €

Scientific publications in indexed journals

12

Total Impact factor

99,56

Nº of articles in Q1 journals

8

Q1 IF

90,484

Nº of articles in Q2 journals

2

Q2 IF

4,801

Anar a l'inici